Sequential combination of PD-1 or PD-L1 inhibitor enhanced GD2-BsAb-driven T cell infiltration and survival of mice, and the tumor-suppressing effect was most effective when anti-PD-1 or anti-PD-L1 antibody treatment was prolonged [62]. The gene discussed is CD274; the disease is neoplasm.